Bruce Bean

Bruce Palmer Bean, PhD

Robert Winthrop Professor of Neurobiology

Neuronal Excitability and Ion Channel Pharmacology

Neurons communicate with each other using electrical impulses. Information is encoded as patterns of “action potentials”, millisecond-long reversals of the voltage across the cell membrane. Different neurons in the brain fire action potentials with a variety of distinct patterns. The Bean lab seeks to understand these different patterns of firing in terms of the underlying molecular devices – tiny pores in the membrane known as ion channels.

In mammalian brains, each neuron possesses several dozen different types of ion channels. Most of these are closed when the neuron is at rest (electrically silent). It is the coordinated, transient opening, or “gating” of particular types of ion channels that underlies electrical signaling. To understand how different combinations of ion channels work together to generate the distinct patterns of action potential firing in different neurons, we make electrical recordings of these cells using patch clamp, voltage clamp and other electrophysiological approaches.

Our goal is to use knowledge of the particular ion channels in different kinds of neurons to find new drugs that can selectively inhibit or enhance electrical activity of specific type of neurons by targeting specific ion channels. In collaboration with Dr. Clifford Woolf’s laboratory, we are currently focused on finding new drugs to treat pain, itch, and cough. We are also seeking to identify new drugs to disrupt epileptic activity.

Publications View
Lidocaine binding enhances inhibition of Nav1.7 channels by the sulfonamide PF-05089771.
Authors: Authors: Jo S, Bean BP.
Mol Pharmacol
View full abstract on Pubmed
Vagal sensory neurons drive mucous cell metaplasia.
Authors: Authors: Talbot S, Doyle B, Huang J, Wang JC, Ahmadi M, Roberson DP, Yekkirala A, Foster SL, Browne LE, Bean BP, Levy BD, Woolf CJ.
J Allergy Clin Immunol
View full abstract on Pubmed
Novel charged sodium and calcium channel inhibitor active against neurogenic inflammation.
Authors: Authors: Lee S, Jo S, Talbot S, Zhang HB, Kotoda M, Andrews NA, Puopolo M, Liu PW, Jacquemont T, Pascal M, Heckman LM, Jain A, Lee J, Woolf CJ, Bean BP.
Elife
View full abstract on Pubmed
Publisher Correction: Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Authors: Authors: Barak B, Zhang Z, Liu Y, Nir A, Trangle SS, Ennis M, Levandowski KM, Wang D, Quast K, Boulting GL, Li Y, Bayarsaihan D, He Z, Feng G.
Nat Neurosci
View full abstract on Pubmed
Deep Sequencing of Somatosensory Neurons Reveals Molecular Determinants of Intrinsic Physiological Properties.
Authors: Authors: Zheng Y, Liu P, Bai L, Trimmer JS, Bean BP, Ginty DD.
Neuron
View full abstract on Pubmed
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Authors: Authors: Barak B, Zhang Z, Liu Y, Nir A, Trangle SS, Ennis M, Levandowski KM, Wang D, Quast K, Boulting GL, Li Y, Bayarsaihan D, He Z, Feng G.
Nat Neurosci
View full abstract on Pubmed
The Role of CaV2.1 Channel Facilitation in Synaptic Facilitation.
Authors: Authors: Weyrer C, Turecek J, Niday Z, Liu PW, Nanou E, Catterall WA, Bean BP, Regehr WG.
Cell Rep
View full abstract on Pubmed
Differential Control of Axonal and Somatic Resting Potential by Voltage-Dependent Conductances in Cortical Layer 5 Pyramidal Neurons.
Authors: Authors: Hu W, Bean BP.
Neuron
View full abstract on Pubmed
Differential Control of Axonal and Somatic Resting Potential by Voltage-Dependent Conductances in Cortical Layer 5 Pyramidal Neurons.
Authors: Authors: Hu W, Bean BP.
Neuron
View full abstract on Pubmed
Breaking barriers to novel analgesic drug development.
Authors: Authors: Yekkirala AS, Roberson DP, Bean BP, Woolf CJ.
Nat Rev Drug Discov
View full abstract on Pubmed